Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Babcock & Wilcox
BW
$1.54B
| $1.27M | ﹤0.01% |
265,180
+158,719
| +149% | +$608K |
|
|
LOAN
2502
Manhattan Bridge Capital
LOAN
$47.2M
| $1.27M | ﹤0.01% |
197,062
-14,640
| -7% | -$91.3K |
|
|
WSTL
2503
DELISTED
Westell Technologies Inc
WSTL
| $1.27M | ﹤0.01% |
932,106
-254
| -0% | -$402 |
|
2504
Koppers
KOP
$885M
| $1.26M | ﹤0.01% |
+43,300
| New | +$1.2M |
|
|
HWCC
2505
DELISTED
Houston Wire & Cable Company
HWCC
| $1.26M | ﹤0.01% |
266,400
+89,700
| +51% | +$416K |
|
2506
Transcat
TRNS
$870M
| $1.25M | ﹤0.01% |
48,986
-27,600
| -36% | -$651K |
|
|
AT
2507
DELISTED
Atlantic Power Corporation
AT
| $1.25M | ﹤0.01% |
534,235
+91,000
| +21% | +$218K |
|
2508
Broadwind
BWEN
$125M
| $1.25M | ﹤0.01% |
737,200
| – | – |
|
2509
Innodata
INOD
$2.1B
| $1.24M | ﹤0.01% |
942,553
+14,319
| +2% | +$17.4K |
|
|
GOOS
2510
Canada Goose Holdings
GOOS
$849M
| $1.24M | ﹤0.01% |
28,200
+21,493
| +320% | +$898K |
|
|
SIC
2511
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $1.23M | ﹤0.01% |
95,000
+24,900
| +36% | +$294K |
|
2512
Assembly Biosciences
ASMB
$631M
| $1.23M | ﹤0.01% |
10,416
-692
| -6% | -$105K |
|
|
CXDC
2513
DELISTED
China XD Plastics Company Limited
CXDC
| $1.23M | ﹤0.01% |
645,980
-100
| -0% | -$208 |
|
|
IOTS
2514
DELISTED
Adesto Technologies Corp
IOTS
| $1.22M | ﹤0.01% |
+142,400
| New | +$1.33M |
|
|
AC
2515
DELISTED
Associated Capital Group
AC
| $1.21M | ﹤0.01% |
34,271
+8,141
| +31% | +$297K |
|
2516
Sabre
SABR
$908M
| $1.21M | ﹤0.01% |
+54,200
| New | +$1.27M |
|
|
MRSN
2517
DELISTED
Mersana Therapeutics
MRSN
| $1.21M | ﹤0.01% |
30,669
+20,028
| +188% | +$1.46M |
|
2518
GATX Corp
GATX
$6.36B
| $1.21M | ﹤0.01% |
15,600
-23,600
| -60% | -$1.8M |
|
|
SHLO
2519
DELISTED
Shiloh Industries Inc
SHLO
| $1.21M | ﹤0.01% |
291,511
-23,300
| -7% | -$106K |
|
|
RPT
2520
Rithm Property Trust
RPT
$104M
| $1.2M | ﹤0.01% |
13,386
-3,674
| -22% | -$308K |
|
|
MFNC
2521
DELISTED
Mackinac Financial Corporation
MFNC
| $1.2M | ﹤0.01% |
77,800
+16,000
| +26% | +$241K |
|
|
UNT
2522
DELISTED
UNIT Corporation
UNT
| $1.2M | ﹤0.01% |
+355,600
| New | +$1.75M |
|
|
NOTV
2523
DELISTED
Inotiv
NOTV
| $1.2M | ﹤0.01% |
334,502
+81,501
| +32% | +$213K |
|
|
RBCN
2524
DELISTED
Rubicon Technology, Inc.
RBCN
| $1.2M | ﹤0.01% |
125,204
+7,916
| +7% | +$71.1K |
|
|
SDRL
2525
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.2M | ﹤0.01% |
570,700
+322,800
| +130% | +$1.02M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.